Logo image
Back
Exercise as adjunctive therapy for systemic lupus erythematosus
Journal article   Open access   Peer reviewed

Exercise as adjunctive therapy for systemic lupus erythematosus

Stephanie Frade, Sean O'Neill, David Greene, Elise Nutter and Melainie Cameron
Cochrane library, Vol.2023(4), p.CD014816
19/04/2023
DOI: https://doi.org/10.1002/14651858.CD014816.pub2
PMID: 37073886
url
Exercise as adjunctive therapy for systemic lupus erythematosusView
Published (Version of record) Open Free to Read

Related links

Metrics

1 Record Views

Abstract

Exanthema Exercise Exercise Therapy  [methods] Fatigue  [etiology]  [therapy] Lupus Erythematosus Systemic  [complications] [therapy] Pain Quality of Life
Background: Systemic lupus erythematosus (SLE) is a rare, chronic autoimmune inflammatory disease with a prevalence varying from 4.3 to 150 people in 100,000, or approximately five million people worldwide. Systemic manifestations frequently include internal organ involvement, a characteristic malar rash on the face, pain in joints and muscles, and profound fatigue. Exercise is purported to be beneficial for people with SLE. For this review, we focused on studies that examined all types of structured exercise as an adjunctive therapy in the management of SLE. Objectives: To evaluate the benefits and harms of structured exercise as adjunctive therapy for adults with SLE compared with usual pharmacological care, usual pharmacological care plus placebo and usual pharmacological care plus non-pharmacological care. Search methods: We used standard, extensive Cochrane search methods. The latest search date was 30 March 2022. Selection criteria: We included randomised controlled trials (RCTs) of exercise as an adjunct to usual pharmacological treatment in SLE compared with placebo, usual pharmacological care alone and another non-pharmacological treatment. Major outcomes were fatigue, functional capacity, disease activity, quality of life, pain, serious adverse events, and withdrawals due to any reason, including any adverse events. Data collection and analysis: We used standard Cochrane methods. Our major outcomes were 1. fatigue, 2. functional capacity, 3. disease activity, 4. quality of life, 5. pain, 6. serious adverse events, and 7. withdrawals due to any reason. Our minor outcomes were 8. responder rate, 9. aerobic fitness, 10. depression, and 11. anxiety. We used GRADE to assess certainty of evidence. The primary comparison was exercise compared with placebo.

Details

Logo image